抗体-药物联合体在肺癌:当前的景观和未来的前景
1Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Current opinion in oncology
|November 12, 2025
概括
抗体-药物合物 (ADC) 正在通过将向抗体输送与强效化疗相结合,彻底改变肺癌治疗. 新的双特异性ADC在克服耐药性和治疗各种肺癌方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体与药物联合体 (ADC) 是肺癌治疗的关键治疗策略.
- ADCs结合了用于瘤向的单克隆抗体和用于杀死细胞的细胞毒性有效载荷.
研究的目的:
- 审查非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 的ADC的结构,机制和临床进展.
- 突出解决瘤异质性和抵抗机制的新型双特异格式.
主要方法:
- 关于ADC发展和肺癌临床试验的当前文献的综述.
- 分析ADC设计的进展,包括有效载荷,链接器和结合技术.
- 专注于新兴目标和两种特定的ADC战略.
主要成果:
- 在生物标志物选择的肺癌患者中观察到ADC的显著临床活性.
- 特拉斯图祖马布德鲁克斯泰坎在HER2突变NSCLC中显示出高疗效,导致监管部门批准.
- 许多新的ADC标正在临床研究中;两种特定的ADC正在出现,以打击异质性和耐药性.
结论:
- 抗癌药物正在改变肺癌疗法,具有强大的疗效和可管理的安全性.
- 下一代双特异性和双相特异性ADC可能会扩大治疗资格并克服耐药性.
- 生物标志物集成和监测对于早期应用和在精密瘤学中建立ADC至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


